This is certainly no substitute for a sound diagnosis. But how can this approach help with the analysis?
Scheuermann: No, the algorithm does not make a diagnosis. But it helps to differentiate: Is it a tumor cell or another cell type? This is achieved through the automated recording and evaluation of a large number of cells. It is therefore a matter of examining the huge amount of data and using the right parameters to highlight various pieces of information.
This information is intended to support and supplement pathological diagnoses in the future. This workflow is currently still in the research phase and is not yet being used in a clinical environment.
The field of application of this procedure is not limited to cancer. In which direction is research still heading?
Scheuermann: The TissueGrinder is primarily about dividing solid tissue into individual cells and improving and standardizing sample preparation processes. Once divided, a wide range of analyses can be carried out. Cancer is undoubtedly one of the main areas, but we are also active in other areas where the isolation of single cells and their analysis is required.
The TissueGrinder technology is characterized in particular by the improvement in sample preparation, which makes it interesting for many different areas of application. One example of this is 3D cell culture. On the one hand, this involves cultivating the isolated cells, and on the other, direct analysis. In addition, it is possible to examine the cells molecularly at the single cell level and thus obtain detailed information about the processes within a cell.
Our approach to ensure that the quality of the starting material is crucial. It is often said "garbage in, garbage out", which means that the quality of the analysis strongly depends on the quality of the starting samples. Therefore, we strive to develop and offer a reproducible and standardized method that minimizes quality loss from the start.